Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11986
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVuletić A.-
dc.contributor.authorJovanic I.-
dc.contributor.authorJurisic, Vladimir-
dc.contributor.authorMilovanovic Z.-
dc.contributor.authorNikolic W.-
dc.contributor.authorSpurnic I.-
dc.contributor.authorKonjević G.-
dc.date.accessioned2021-04-20T19:43:39Z-
dc.date.available2021-04-20T19:43:39Z-
dc.date.issued2015-
dc.identifier.issn1219-4956-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/11986-
dc.description.abstract© 2015, Arányi Lajos Foundation. As lymphogenic dissemination is very common in melanoma, regional lymph nodes (LN)s represent first immunological barriers to tumor invasion and play a complex role in antitumor immune defense. In this sense, their most prominent role is the presentation of tumor-derived antigens to naïve T cells and generation of cell-mediated adaptive immune response. Since tumor micro-environment affects immune cell function in this study we have evaluated the ability of T cells and NK cells in metastatic (involved) and non-metastatic regional LNs to produce interferon γ (IFNγ), a pleiotropic cytokine that regulates adaptive antitumor immune response. Our results show reduced IFNγ production in both T and NK lymphocyte subsets and decreased prevalence of T cells in metastatic regional LNs of melanoma patients. The decrease of IFNγ production in T cells was more pronounced with increased number of involved regional LNs indicating tumor-induced functional impairment of both T and NK cell lymphocyte subsets in involved regional LNs. Therefore, shown low IFNγ production in metastatic LNs may represent an obstacle in adaptive cell-mediated antitumor immune response and hence may enable tumor progression.-
dc.rightsrestrictedAccess-
dc.sourcePathology and Oncology Research-
dc.titleDecreased Interferon γ Production in CD3<sup>+</sup> and CD3<sup>−</sup>CD56<sup>+</sup> Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients-
dc.typearticle-
dc.identifier.doi10.1007/s12253-015-9938-3-
dc.identifier.scopus2-s2.0-84940447235-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

142

Downloads(s)

6

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.